Class IOngoing

FOUZEE SugarLin HERBAL FORMULA capsules recall

FDA recall D-0207-2025 · initiated Dec 16, 2024

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide

Details

Product: FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7
Recalling company: SHOPPERS- PLAZA
Classification: Class I
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Nationwide via internet sales
Initiated: Dec 16, 2024
FDA report date: Jan 29, 2025

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0207-2025 ↗

← All drug recalls